SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
ulcerative colitis
Journals
19
1
Journal of ethnopharmacology
2
PloS one
3
International journal of molecular sciences
4
inflammatory bowel diseases
5
clinical microbiology reviews
6
family medicine
7
Journal of gastroenterology and hepatology
8
klinicheskaia laboratornaia diagnostika
9
clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association
10
clinical and experimental immunology
11
international dental journal
12
experimental and therapeutic medicine
13
Gut
14
Neurology(R) neuroimmunology & neuroinflammation
15
modern rheumatology
16
journal of biomechanical engineering
17
biochemistry and cell biology = biochimie et biologie cellulaire
18
folia medica cracoviensia
19
Journal of medical ultrasonics (2001)
Research Groups
0
No Research Group Connected
Bibliographies
125
1
The epidemiology of inflammatory bowel disease: East meets West.
2
Training Residents in Maternal Depression Care to Improve Child Health: A CERA Study.
3
Measuring Three-dimensional Knee Kinematics Using a Femoral Clamp: Accuracy, Repeatability and Reproducibility in Gait.
4
Successful development of methodology for detection of hapten-specific contact hypersensitivity (CHS) memory in swine.
5
The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
6
How does the method change what we measure? Comparing virtual reality and text-based surveys for the assessment of moral decisions in traffic dilemmas.
7
Inter-individual genomic heterogeneity within European population isolates.
8
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.
9
Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology.
10
Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.
11
Comparison of the efficacy of available statistical methods for prediction of the hospitalizations number: proof of concept and validation based on the analysis of Polish National Health Fund data in the years 2009-2017.
12
Diet in treatment of Inflammatory Bowel Diseases.
13
Pathobionts Associated with Inflammatory Bowel Disease.
14
Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease.
15
Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
16
nrf-2 expression in ulcerative colitis lesions and its correlation with antioxidant enzyme levels and tissue injury
17
Вікові особливості стану печінки у хворих на хронічні запальні захворювання кишечника за даними стеатометрії та зсувнохвильової еластометрії
18
central role of the gut epithelial barrier in pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics
19
markers of hypoxia correlate with histologic and endoscopic severity of colitis in inflammatory bowel disease
20
vedolizumab in patients with inflammatory bowel diseases of in real clinical practice
21
intestinal epithelium in inflammatory bowel disease
22
rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
23
qualidade de vida de pacientes portadores de doença inflamatória intestinal calidad de vida de pacientes portadores de enfermedad inflamatoria intestinal quality of life of patients with inflammatory bowel disease
24
state of igg4-positive plasma cells in the colon mucosa of chronic inflammatory bowel disease
25
quality of life in the late follow-up of ulcerative colitis patients submitted to restorative proctocolectomy with sphincter preservation over ten years ago
26
exercise in patients with inflammatory bowel diseases: current perspectives
27
a randomized clinical trial of vitamin d3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis d3
28
¿cuándo es demasiado pronto y cuándo demasiado tarde para la cirugía en la enfermedad de crohn? when is it too early or too late for surgery in crohn's disease?
29
endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study
30
application of 5-aminosalicylic acid preparations in the treatment of inflammatory bowel diseases
31
detection of intestinal flora levels as well as cytokine and tlrs molecule expression in patients with ulcerative colitis
32
drugs as causative agents and therapeutic agents in inflammatory bowel disease
33
imaging of mucosal inflammation: current technological developments, clinical implications, and future perspectives
34
anti-inflammatory effects of herbal preparations stw5 and stw5-ii in cytokine-challenged normal human colon cells.
35
Vitamin D and Ulcerative Colitis: Is There a Relationship with Disease Extent?
36
Diagnosis of ulcerative colitis and Crohn's disease using transabdominal ultrasonography.
37
Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation.
38
The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis
39
The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
40
Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression
41
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
42
Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
43
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
44
The combination of indirubin and isatin attenuates dextran sodium sulfate induced ulcerative colitis in mice.
45
Endoscopy in Postoperative Patients with Crohn's Disease or Ulcerative Colitis. Does It Translate to Better Outcomes?
46
[Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.]
47
Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.
48
Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis
49
Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis
50
Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
51
Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology
52
Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?
53
Functional and quality of life outcomes after ileal pouch-anal anastomosis in short versus long ileal J-pouch configuration in ulcerative colitis patients: a cohort study.
54
Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats.
55
Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis
56
Ulcerative Colitis: A Critical Approach to the Global Research Output Employing Density-equalizing Mapping and Scientometric Methods.
57
Effects of Aqueous and Methanolic Extracts of Stem Bark of De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats.
58
Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study.
59
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
60
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1
61
Chemotaxonomic Analysis of Bacterial Populations Colonizing the Rectal Mucosa in Patients with Ulcerative Colitis
62
Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
63
Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
64
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis
65
Vedolizumab for induction and maintenance of remission in ulcerative colitis
66
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
67
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
68
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
69
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
70
Vedolizumab as induction and maintenance therapy for ulcerative colitis
71
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
72
Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life
73
Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life
74
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients
75
expressing the differences between crohn disease and ulcerative colitis.
76
intestinal giardiasis disguised as ulcerative colitis
77
cause for controversy? infliximab in the treatment of ulcerative colitis: an update
78
decreased breg/th17 ratio improved the prognosis of patients with ulcerative colitis
79
topical treatment of ulcerative colitis using enemas containing 5-aminosalicylic acid and beclomethasone dipropionate
80
myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis
81
the red hearing: swollen ear in a patient with ulcerative colitis
82
optimal management of steroid-dependent ulcerative colitis
83
body composition as an indicator of the nutritional status in children with newly diagnosed ulcerative colitis and crohn’s disease – a prospective study
84
bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis
85
the value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis
86
pas de deux: active ulcerative colitis in an hiv-positive patient
87
update on the management of ulcerative colitis: treatment and maintenance approaches focused on mmx® mesalamine
88
protective effect of amphipterygium adstringens extract on dextran sulphate sodium-induced ulcerative colitis in mice
89
the transient receptor potential vanilloid 1 is associated with active inflammation in ulcerative colitis
90
dysplasia risk in ileal pouches after reconstructive surgery for ulcerative colitis
91
fibre utilisation is not defective but colonic epithelial function may be abnormal in quiescent ulcerative colitis
92
anti-ulcerative colitis activity of calotropis procera linn.
93
soluble interleukin-2 receptors in ulcerative colitis
94
quality of life in patients with ileal pouch for ulcerative colitis
95
kangfuxinye enema combined with mesalamine for ulcerative colitis: a systematic review and grade approach
96
quantitative analysis of intestinal flora of uygur and han ethnic chinese patients with ulcerative colitis
97
efficacy of curcumin as adjuvant therapy to induce or maintain remission in ulcerative colitis patients: an evidence-based clinical review
98
rapid progression of primary sclerosing cholangitis complicated with ulcerative colitis
99
maintaining remission in distal ulcerative colitis and ulcerative proctitis
100
pr3anca related cerebral vasculitis in ulcerative colitis presenting with orbital involvement: a case report with review of literature
101
ulcerative colitis and systemic sclerosis